X @Bloomberg
LillyLilly(US:LLY) Bloomberg·2026-03-20 00:32

England’s drug price regulator will have to reconsider its decision to rule out using Eli Lilly’s Alzheimer’s drug in the state-run National Health Service, following a successful appeal by the US drugmaker https://t.co/fWXon8Qsap ...